Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gatorbulin-1, a distinct cyclodepsipeptide chemotype, targets a seventh tubulin pharmacological site
Susan Matthew, Qi-Yin Chen, Ranjala Ratnayake, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 9
Open Access | Times Cited: 67

Showing 26-50 of 67 citing articles:

Conformational changes in tubulin upon binding cryptophycin-52 reveal its mechanism of action
Elif Eren, Norman R. Watts, Dan L. Sackett, et al.
Journal of Biological Chemistry (2021) Vol. 297, Iss. 4, pp. 101138-101138
Open Access | Times Cited: 16
Discovery of potent tubulin inhibitors targeting the colchicine binding site via structure-based lead optimization and antitumor evaluation
Wei Liu, Youyou He, Zhongjie Guo, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 7
Design, Synthesis, and Evaluation of An Anti‐trypanosomal [1,2,4]Triazolo[1,5‐a]pyrimidine Probe for Photoaffinity Labeling Studies
Bobby Lucero, Karol R. Francisco, Carmine Varricchio, et al.
ChemMedChem (2024) Vol. 19, Iss. 8
Open Access | Times Cited: 2
PM534, an Optimized Target-Protein Interaction Strategy through the Colchicine Site of Tubulin
Daniel Lucena‐Agell, María José Guillén, Ruth Matesanz, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 4, pp. 2619-2630
Open Access | Times Cited: 2
Discovery of novel thiophene[3,2-d]pyrimidine-based tubulin inhibitors with enhanced antitumor efficacy for combined use with anti-pd-l1 immunotherapy in melanoma
Chenglong Xu, Chengyong Wu, Ling Li, et al.
European Journal of Medicinal Chemistry (2024) Vol. 277, pp. 116791-116791
Closed Access | Times Cited: 2
Chemical diversity of cyanobacterial natural products
Márcio Barczyszyn Weiss, Ricardo M. Borges, Peter Sullivan, et al.
Natural Product Reports (2024)
Closed Access | Times Cited: 2
Discovery of novel tubulin inhibitors targeting the colchicine binding site via virtual screening, structural optimization and antitumor evaluation
Wei Liu, Hairui Jia, Minghao Guan, et al.
Bioorganic Chemistry (2021) Vol. 118, pp. 105486-105486
Closed Access | Times Cited: 15
Synthesis, modeling, and biological evaluation of anti-tubulin indole-substituted furanones
Brianna M. Hurysz, Blake Evans, Reuben N. Laryea, et al.
Bioorganic & Medicinal Chemistry Letters (2023) Vol. 90, pp. 129347-129347
Open Access | Times Cited: 5
Synthesis by diastereomeric resolution, biochemical evaluation and molecular modelling of chiral 3-hydroxyl b-lactam microtubule-targeting agents for the treatment of triple negative breast and chemoresistant colorectal cancers
Eavan C. McLoughlin, Brendan Twamley, John E. O’Brien, et al.
Bioorganic Chemistry (2023) Vol. 141, pp. 106877-106877
Open Access | Times Cited: 5
Trikoveramides A-C, cyclic depsipeptides from the marine cyanobacterium Symploca hydnoides
Ma Yadanar Phyo, Nursheena Parveen Katermeran, Jun Xian Goh, et al.
Phytochemistry (2021) Vol. 190, pp. 112879-112879
Closed Access | Times Cited: 12
Structure‐Activity Relationships, Tolerability and Efficacy of Microtubule‐Active 1,2,4‐Triazolo[1,5‐a]pyrimidines as Potential Candidates to Treat Human African Trypanosomiasis**
Ludovica Monti, Lawrence J. Liu, Carmine Varricchio, et al.
ChemMedChem (2023) Vol. 18, Iss. 20
Open Access | Times Cited: 4
Secondary metabolites from cyanobacteria: source, chemistry, bioactivities, biosynthesis and total synthesis
Yanchun He, Ying Chen, Huaming Tao, et al.
Phytochemistry Reviews (2024)
Closed Access | Times Cited: 1
Design, Synthesis, and Biological Evaluation of 5,6,7,8-Tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidines as Microtubule Targeting Agents
Farhana Islam, Arpit Doshi, Andrew J. Robles, et al.
Molecules (2022) Vol. 27, Iss. 1, pp. 321-321
Open Access | Times Cited: 7
Discovery of potent microtubule-destabilizing agents targeting for colchicine site by virtual screening, biological evaluation, and molecular dynamics simulation
Hui Zhang, Qing-Qing Luo, Mei-Ling Hu, et al.
European Journal of Pharmaceutical Sciences (2022) Vol. 180, pp. 106340-106340
Open Access | Times Cited: 7
Synthesis, biological and computational evaluation of novel cyanomethyl vinyl ether derivatives
Endika Martín‐Encinas, Marı́a Fuertes, Samuel Delgado‐Hernández, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Synthesis, in-silico, in-vitro evaluation of furanyl- and thiophenyl-3-phenyl-1H-indole-2-carbohydrazide derivatives as tubulin inhibitors and anticancer agents
Rungroj Saruengkhanphasit, Lukana Ngiwsara, Kriengsak Lirdprapamongkol, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 7, pp. 2483-2495
Closed Access | Times Cited: 1
Discovery and biological profile of pyridachlometyl
Yuichi Matsuzaki, Makoto Kurahashi, Satoshi Watanabe, et al.
Pest Management Science (2024)
Open Access | Times Cited: 1
Combretastatin A-4 based compounds as potential anticancer agents: A review
Moien A. Omar, Soha H. Emam, Demiana S. Mikhail, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107930-107930
Closed Access | Times Cited: 1
Design, Synthesis, and in vitro Evaluation of Tubulin‐Targeting Dibenzothiazines with Antiproliferative Activity as a Novel Heterocycle Building Block
Walter D. Guerra, Daniel Lucena‐Agell, Rafael Hortigüela, et al.
ChemMedChem (2021) Vol. 16, Iss. 19, pp. 3003-3016
Closed Access | Times Cited: 9
Alternative Approaches to Understand Microtubule Cap Morphology and Function
María A. Oliva, Federico Gago, Shinji Kamimura, et al.
ACS Omega (2023) Vol. 8, Iss. 4, pp. 3540-3550
Open Access | Times Cited: 3
Antiproliferative and Tubulin-Destabilising Effects of 3-(Prop-1-en-2-yl)azetidin-2-Ones and Related Compounds in MCF-7 and MDA-MB-231 Breast Cancer Cells
Shu Wang, Azizah M. Malebari, Thomas F. Greene, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 7, pp. 1000-1000
Open Access | Times Cited: 3
Discovery of pyrimidine-bridged CA-4 CBSIs for the treatment of cervical cancer in combination with cisplatin with significantly reduced nephrotoxicity
Zhipeng Huo, Kunlin Liu, Xi Zhang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 235, pp. 114271-114271
Closed Access | Times Cited: 5
Anti-lung cancer properties of cyanobacterial bioactive compounds
Mirza S. Baig, Sajjan Rajpoot, Tomokazu Ohishi, et al.
Archives of Microbiology (2022) Vol. 204, Iss. 10
Closed Access | Times Cited: 5
Chemical modulation of microtubule structure through the laulimalide/peloruside site
Juan Estévez-Gallego, Beatriz Álvarez‐Bernad, Benet Pera, et al.
Structure (2022) Vol. 31, Iss. 1, pp. 88-99.e5
Open Access | Times Cited: 5
Lead optimization of novel quinolone chalcone compounds by a structure–activity relationship (SAR) study to increase efficacy and metabolic stability
James Knockleby, Aïcha Dede Djigo, Indeewari K.S. Lindamulage, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 7

Scroll to top